When President Trump announced a new deal Friday to lower prescription drug costs, it was the clearest sign yet that he'd paused his commerce secretary's push to slap 100% tariffs on pharmaceuticals that aren't manufactured in the U.S.
Why it matters: Prescription drug policy and tariffs are big priorities of Trump's administration. But after the two issues collided in a conflicting series of White House messages recently, Trump set aside the tariffs idea, which could have made drugs more expensive for many Americans.
President Trump's second "routine yearly checkup" on Friday determined that he is in "exceptional health."
The big picture: Trump has downplayed concerns about his age and health since returning to the White House. He was diagnosed with chronic venous insufficiency in July after experiencing mild swelling in his lower legs.
For years, patients have had to navigate a maze of conflicting mammogram advice. Now, artificial intelligence could help cut through the noise — by tailoring breast cancer screening schedules to individual risk.
Why it matters: AI is beginning to bridge the gap between one-size-fits-all screening guidelines and personalized medicine. By analyzing thousands of mammograms and patient outcomes, new tools can help doctors better identify who's at highest risk — and when they should be screened.
